Financials
Financial year 2025
Worth noting
- Little cash and receivables against the short-term debts.
Revenue
€ 1.2 million
Profit
Growing€ 2.2 million
▲ 850% vs 2024
Debts
Normal€ 12.6 million
▼ 12% vs 2024
ANTWERP PHARMACIES from Sint-Truiden, company number BE0700733344, closed financial year 2025 with a result of € 2.2 million after tax. For that financial year ANTWERP PHARMACIES recorded revenue of € 1.2 million and equity of € 4.3 million. Compared with financial year 2024, the result moved from € 234,041 to € 2.2 million. Profitable, and profit is growing. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on July 10, 2026.
What happened at ANTWERP PHARMACIES?
What happened at ANTWERP PHARMACIES in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 2.2 million (▲ 850% vs 2024). Source: NBB ↗
- Darwin NV became a director. NBB
- Jeff Roskams Consulting BV became a director. NBB
- New establishment in Antwerpen. KBO
- Start of the company according to the CBE. KBO
In short
From € 497,361 profit in 2021 to € 2.2 million profit in 2025.
Paid € 493,090 in corporate taxes since 2021.
Best year ever: 2025, with € 2.2 million profit.
On average € 275,100 of value added per employee in 2024.
A new publication or filing at ANTWERP PHARMACIES? We notify you, reason included.
Follow ANTWERP PHARMACIESNeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
Behind ANTWERP PHARMACIES are Jeff Roskams Consulting BV and Darwin NV. It owns 100% of International Apotheek, 100% of Verlinden Apotheek, 100% of Dirk Van Herck Apotheek, 100% of Krols Apotheek, 100% of Suykerbuyk Apotheek and 100% of Europa Apotheek itself.
Directors
According to the 2025 annual accounts
Director · represented by Jeff Roskams
Also active at: INTERNATIONALE APOTHEEK, APOTHEEK VERLINDEN
since 2019
Director · represented by Joris Mees
Also active at: APOTHEEK ELZEDORP, MEES MANAGEMENT APOTHEEK, Columbus Group +9 more
since 2020
Establishments
Establishment units
Physical locations of this company
N.B. de Borchgravestraat 4430
3800 Sint-Truiden
Groenplaats 42
2000 Antwerpen
Active since 8 August 2018
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 5 companies are registered at this address.
Details
- Company number
- 0700.733.344
- VAT number
- BE 0700.733.344
- Registered office
- N.B. de Borchgravestraat 4430, 3800 Sint-Truiden
- Names & denominations
- ANTWERP PHARMACIES
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 8 August 2018
- Peppol
- Active · Active since 12 Jan 2026
- Activities · NACE
Detailhandel in farmaceutische producten
Activiteiten van holdings
Holdings
Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies
Verhuur en exploitatie van eigen of geleased residentieel onroerend goed, exclusief sociale woningen
Handel in eigen onroerend goed
Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering